Bioscrip reported $76.35M in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Addus Homecare ADUS:US $ 21.96M 3.13M
Amedisys AMED:US $ 62.48M 2.78M
Bioscrip BIOS:US $ 76.35M 8.12M
Biotelemetry BEAT:US $ -3.54M 1.39M
Chemed CHE:US $ 103.52M 0.76M
Community Health Systems CYH:US $ 244M 113M
Cross Country Healthcare CCRN:US $ 81.2M 14.41M
CVS Health CVS:US $ 5656M 586M
Davita Healthcare Partners DVA:US $ 594.75M 90.54M
Encompass Health Corp EHC:US $ 233.2M 16.9M
Enzo Biochem ENZ:US $ -1.67M 3.3M
HCA HCA:US $ 3034M 101M
Laboratory Of America LH:US $ 751.4M 111.8M
LHC LHCG:US $ 45.31M 2.94M
Mednax MD:US $ 64.27M 14.97M
Molina Healthcare MOH:US $ 416M 12M
Quest Diagnostics DGX:US $ 495M 136M
Radnet RDNT:US $ 48.6M 19.68M
Surmodics SRDX:US $ -4.94M 2.36M
Tenet Healthcare THC:US $ 695M 210M
Us Physical Therapy USPH:US $ 23.55M 4.7M